Phase 1 Study of MPC-6827 and Temozolomide in Metastatic Melanoma

Clinical trial NCT00609011 · COMPLETED

Trial details

NCT number: NCT00609011
Sponsor: Myrexis Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Melanoma

Start date: 2008-03-01
Primary completion: 2009-08-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.